Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05615298 · ClinicalTrials.gov registry record
Study to Evaluate Effectiveness of Investigational Device in the Assistance of Detection and Diagnosis of Breast Cancer
A clinical trial, sponsored by Lunit.
- Completed
- Registry status
- 240
- Enrollment target
NCT05615298: Completed study, sponsored by Lunit.
NCT05615298 is a clinical trial that has completed, run by Lunit. The registered enrollment target is 240 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05615298 has completed, sponsored by Lunit.
- COMPLETED
- Registry status
- 240 participants
- Enrollment target
Study Summary
This study aims to evaluate Effectiveness of Investigational Device, Lunit INSIGHT MMG, in the assistance of Detection and Diagnosis of Breast Cancer during Screening Mammography Interpretation.
Interventions
- RADIATION Mammography
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2020-06-15 |
| Est. Completion | 2021-01-13 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05615298
The ClinicalTrials.gov registry entry for NCT05615298 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 240 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Lunit, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Mammography is the first listed.
NCT05615298 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05615298 about?
NCT05615298 is a clinical study titled "Study to Evaluate Effectiveness of Investigational Device in the Assistance of Detection and Diagnosis of Breast Cancer". This study aims to evaluate Effectiveness of Investigational Device, Lunit INSIGHT MMG, in the assistance of Detection and Diagnosis of Breast Cancer during Screening Mammography Interpretation.
What is the current status of trial NCT05615298?
This trial is currently completed. The enrollment target is 240 participants. The study started on 2020-06-15. Estimated completion is 2021-01-13.
What interventions are being tested in trial NCT05615298?
The interventions under investigation include: Mammography (RADIATION).
Who is sponsoring clinical trial NCT05615298?
This trial is sponsored by Lunit, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.